Citation: Mj. Edwards et al., INFILTRATING DUCTAL CARCINOMA OF THE BREAST - THE SURVIVAL IMPACT OF RACE, Journal of clinical oncology, 16(8), 1998, pp. 2693-2699
Authors:
SHPALL EJ
CHAMPLIN RE
EAVES AC
GEE AP
COLLINS N
LEMAISTRE CF
OREILLY R
ROWLEY SD
SULLIVAN K
VAUGHAN WP
WARKENTIN PL
Citation: Ej. Shpall et al., FOUNDATION FOR THE ACCREDITATION OF HEMATOPOIETIC-CELL THERAPY (FAHCT) RESPONSE TO FDA (DOCKET NO.97N-0068), Journal of hematotherapy, 6(4), 1997, pp. 287-289
Authors:
KIM MH
WRIGHT M
DESHANE J
ACCAVITTI MA
TILDEN A
SALEH M
VAUGHAN WP
CARABASI MH
ROGERS MD
HOCKETT RD
GRIZZLE WE
CURIEL DT
Citation: Mh. Kim et al., A NOVEL GENE-THERAPY STRATEGY FOR ELIMINATION OF PROSTATE CARCINOMA-CELLS FROM HUMAN BONE-MARROW, Human gene therapy, 8(2), 1997, pp. 157-170
Authors:
ANTMAN KH
ROWLINGS PA
VAUGHAN WP
PELZ CJ
FAY JW
FIELDS KK
FREYTES CO
GALE RP
HILLNER BE
HOLLAND HK
KENNEDY MJ
KLEIN JP
LAZARUS HM
MCCARTHY PL
SAEZ R
SPITZER G
STADTMAUER EA
WILLIAMS SF
WOLFF S
SOBOCINSKI KA
ARMITAGE JO
HOROWITZ MM
Citation: Kh. Antman et al., HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT FOR BREAST-CANCER IN NORTH-AMERICA, Journal of clinical oncology, 15(5), 1997, pp. 1870-1879
Authors:
MANN SL
JOSHI SS
CROUSE DA
ARMITAGE JO
KESSINGER A
WEISENBURGER DD
VAUGHAN WP
SHARP JG
Citation: Sl. Mann et al., INCREASED HEMATOPOIETIC PROGENITOR-CELL MAINTENANCE IN LONG-TERM BONE-MARROW CULTURES CONTAINING MINIMAL NUMBERS OF CONTAMINATING BREAST-CANCER CELLS, Breast cancer research and treatment, 44(2), 1997, pp. 115-121
Authors:
MATTAR B
CARABASI MH
TILDEN AB
SALZMAN D
MARTIN B
KUNKEL L
VAUGHAN WP
Citation: B. Mattar et al., IMPROVED OUTCOME IN RECIPIENTS OF HLA IDENTICAL T-CELL DEPLETED ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTS CONTAINING HIGH-DOSES OF STEM-CELLS, Blood, 90(10), 1997, pp. 4421-4421
Authors:
MEEKS MC
TILDEN A
SALZMAN DE
CARABASI MH
VAUGHAN WP
Citation: Mc. Meeks et al., IMPROVED PROGRESSION FREE AND OVERALL SURVIVAL IN RELAPSED NON-HODGKIN-LYMPHOMA (NHL) TREATED WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) USING A BUSULFAN BASED PREPARATIVE REGIMEN, Blood, 90(10), 1997, pp. 4567-4567
Authors:
CARABASI MH
TILDEN AB
SHRESTRA K
SALZMAN D
MARTIN B
VAUGHAN WP
KUNKEL L
BUCY RP
Citation: Mh. Carabasi et al., RAPID IMMUNE RECONSTITUTION IN RECIPIENTS OF T-CELL DEPLETED PERIPHERAL-BLOOD STEM-CELL TRANSPLANTS FROM ALA IDENTICAL SIBLINGS, Blood, 90(10), 1997, pp. 2415-2415
Citation: De. Salzman et al., BONE-MARROW TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMA - A REVIEW, The American journal of the medical sciences, 313(4), 1997, pp. 228-235
Authors:
CARABASHI MH
TILDEN AB
SHRESTRA K
SALZMAN D
MARTIN B
VAUGHAN WP
LEBKOWSKI JS
BUCY RP
Citation: Mh. Carabashi et al., IMPACT OF CD8 DEPLETED DONOR LEUKOCYTE INFUSIONS ON IMMUNE FUNCTION IN RECIPIENTS OF HLA-IDENTICAL T-CELL DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTS, Blood, 88(10), 1996, pp. 1831-1831
Authors:
ANDERSSON BS
MADDEN T
STANFIELD L
HU W
CHOW DSL
BLUME K
WILLIAMS TE
VAUGHAN WP
CHAMPLIN RE
Citation: Bs. Andersson et al., PRETRANSPLANTATION CONDITIONING THERAPY WITH IV BUSULFAN CYCLOPHOSPHAMIDE (BUCY) - A PHASE-I STUDY/, Blood, 88(10), 1996, pp. 2372-2372
Authors:
VAUGHAN WP
KRIS E
VOSE J
BIERMAN PJ
GWILT P
ARMITAGE JO
Citation: Wp. Vaughan et al., PHASE I II STUDY INCORPORATING INTRAVENOUS HYDROXYUREA INTO HIGH-DOSECHEMOTHERAPY FOR PATIENTS WITH PRIMARY REFRACTORY OR RELAPSED AND REFRACTORY INTERMEDIATE-GRADE AND HIGH-GRADE MALIGNANT-LYMPHOMA/, Journal of clinical oncology, 13(5), 1995, pp. 1089-1095
Authors:
TRACEWELL WG
TRUMP DL
VAUGHAN WP
SMITH DC
GWILT PR
Citation: Wg. Tracewell et al., POPULATION PHARMACOKINETICS OF HYDROXYUREA IN CANCER-PATIENTS, Cancer chemotherapy and pharmacology, 35(5), 1995, pp. 417-422
Authors:
LIU Y
CARABASI MH
VAUGHAN WP
COOPER MD
PRCHAL JT
Citation: Y. Liu et al., LINEAGE DIVERGENT CLONAL RESTORATION OF HEMATOPOIESIS AFTER SUCCESSFUL ALLOGENIC MARROW TRANSPLANTATION (BMT), Blood, 86(10), 1995, pp. 394-394
Authors:
SALZMAN D
CARABASI MA
BRIGGS AD
GEILS GF
VAUGHAN WP
Citation: D. Salzman et al., HIGH-DOSE CHEMOTHERAPY (HDC) AND AUTOLOGOUS BLOOD OR MARROW TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMA (NHL) AND HODGKINS-DISEASE (HD) AT RISK FOR PULMONARY COMPLICATIONS, Blood, 86(10), 1995, pp. 3840-3840
Citation: Wp. Vaughan et al., HIGH-DOSE CYCLOPHOSPHAMIDE, THIOTEPA AND HYDROXYUREA WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL RESCUE - AN EFFECTIVE CONSOLIDATION CHEMOTHERAPY REGIMEN FOR EARLY METASTATIC BREAST-CANCER, Bone marrow transplantation, 13(5), 1994, pp. 619-624
Citation: Gf. Geils et al., RAPID PLATELET RECOVERY-TIME FOLLOWING HIGH-DOSE CHEMOTHERAPY (HDT) FOR METASTATIC BREAST-CANCER SUPPORTED BY HEMATOPOIETIC STEM-CELLS COLLECTED FROM BLOOD (BSC) AFTER G-CSF ADMINISTRATION, Blood, 84(10), 1994, pp. 10000709-10000709
Authors:
METCALF JP
RENNARD SI
REED EC
HAIRE WD
SISSON JH
WALTER T
ROBBINS RA
ARMITAGE JO
ARNESON M
BIERMAN PJ
CURSEEN AF
DARRINGTON D
DICKE KA
HUERTA G
JONES K
KESSINGER A
RICKARD KA
ROMBERGER DJ
RUBENSTEIN I
SHUMWAY M
SPURZEM JR
THOMPSON AB
VAUGHAN WP
VONESSEN SG
VOSE JM
YATES RS
Citation: Jp. Metcalf et al., CORTICOSTEROIDS AS ADJUNCTIVE THERAPY FOR DIFFUSE ALVEOLAR HEMORRHAGEASSOCIATED WITH BONE-MARROW TRANSPLANTATION, The American journal of medicine, 96(4), 1994, pp. 327-334
Citation: Dc. Smith et al., A PHASE-I TRIAL OF HIGH-DOSE CONTINUOUS-INFUSION HYDROXYUREA, Cancer chemotherapy and pharmacology, 33(2), 1993, pp. 139-143
Citation: Wp. Vaughan, AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN THE TREATMENT OF BREAST-CANCER - CLINICAL AND TECHNOLOGIC STRATEGIES, Seminars in oncology, 20(5), 1993, pp. 55-58
Citation: Kj. Warner et al., ALLOGENEIC BONE-MARROW TRANSPLANT WITHOUT NECESSARY RBC OR PLATELET TRANSFUSION SUPPORT IN A PATIENT WITH PRIOR SPLENECTOMY, Blood, 82(10), 1993, pp. 10000644-10000644